β-ketoacyl synthase inhibitors belong to a specialized category of chemical compounds designed to target and modulate the activity of β-ketoacyl synthase enzymes, which are essential components of fatty acid biosynthesis in living organisms. Fatty acids serve as crucial molecules in various biological processes, including energy storage, cell membrane construction, and signal transduction. β-ketoacyl synthase enzymes play a pivotal role in the elongation cycle of fatty acid synthesis, where they catalyze the condensation of malonyl-ACP (malonyl-acyl carrier protein) with a growing acyl chain, leading to the formation of longer fatty acid chains. Inhibitors of β-ketoacyl synthases are developed to interact with these specific enzymes, disrupting their catalytic activities or altering their ability to participate in fatty acid biosynthesis processes.
Structurally, β-ketoacyl synthase inhibitors are meticulously designed to engage specific regions or binding sites on the enzyme. This interaction may interfere with the normal functioning of β-ketoacyl synthases, impacting the elongation cycle of fatty acid synthesis and, consequently, affecting the production of fatty acids. The mechanisms by which β-ketoacyl synthase inhibitors exert their effects can vary, but their primary objective is to serve as valuable tools for researchers studying fatty acid metabolism and related cellular processes. Investigating the biochemical and functional aspects of β-ketoacyl synthases and their modulation by inhibitors can contribute to a deeper understanding of lipid metabolism, cellular membrane construction, and the broader field of molecular and cellular biology. Ultimately, such research can offer insights into the intricate molecular mechanisms that govern fundamental cellular functions and their regulation by β-ketoacyl synthase enzymes.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $158.00 $306.00 $1186.00 | 9 | |
Cerulenin specifically inhibits β-ketoacyl synthase, thereby disrupting fatty acid synthesis. | ||||||
Platensimycin | 835876-32-9 | sc-202292 | 250 µg | $453.00 | 1 | |
Platensimycin is an antibiotic that acts by inhibiting β-ketoacyl synthase, thereby disrupting bacterial fatty acid synthesis. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin has been shown to inhibit β-ketoacyl synthase activity, thereby affecting lipid metabolism. | ||||||
Isoniazid | 54-85-3 | sc-205722 sc-205722A sc-205722B | 5 g 50 g 100 g | $25.00 $99.00 $143.00 | ||
Primarily an anti-tubercular agent, isoniazid can also inhibit mycolic acid biosynthesis by targeting β-ketoacyl synthase. | ||||||
Pyrazinamide | 98-96-4 | sc-205824 sc-205824A sc-205824B sc-205824C sc-205824D sc-205824E | 10 g 25 g 100 g 250 g 1 kg 5 kg | $48.00 $66.00 $87.00 $148.00 $474.00 $2231.00 | ||
Pyrazinamide disrupts mycolic acid synthesis in mycobacteria, and one of its targets is the β-ketoacyl synthase. | ||||||
Triclosan | 3380-34-5 | sc-220326 sc-220326A | 10 g 100 g | $138.00 $400.00 | ||
Triclosan inhibits enoyl-acyl carrier protein reductase (not directly β-ketoacyl synthase), but it impacts the same fatty acid synthesis pathway. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
Although primarily an antifungal, ketoconazole has been noted to affect lipid metabolism, potentially through β-ketoacyl synthase inhibition. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $117.00 $469.00 | 18 | |
Fumonisin B1 is a mycotoxin that can inhibit ceramide synthase, but it may also have downstream effects on β-ketoacyl synthase activity. | ||||||
Toosendanin | 58812-37-6 | sc-474759 | 2.5 mg | $330.00 | ||
Toosendanin has demonstrated inhibitory effects on β-ketoacyl synthase, affecting lipid synthesis. |